ArticleBMC psychiatry2026
An explainable machine learning model for predicting depressive symptoms among Chinese older adults with chronic diseases.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Machine learning in mental health promotion for older adults: a scoping review.BMC geriatrics · 2026Article
- Development of a machine learning-based screening model for the risk of depression among the elderly in China.BMC geriatrics · 2026Article
- Prediction of depressive symptoms in middle-aged and older adult hospitalized patients with chronic diseases: a multicenter study in Anhui, China using machine learning methods.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression is a multifactorial disorder whose coexistence with chronic diseases imposes a substantial health burden and complicates the identification of at-risk older adults. To address this, we analyzed seven-dimensional data derived from the China Health and Retirement Longitudinal Study (CHARLS) and applied machine learning (ML) to predict depressive symptoms among older adults with chronic diseases.
methodsParticipants from wave 4 of CHARLS were included. Depressive symptoms were assessed using the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10), with a total score > 12 indicating clinically significant depressive symptoms. Five ML models were trained using 70% of the dataset and validated on the remaining 30%. Hyperparameters were optimized using grid search combined with five-fold cross-validation. Feature importance was calculated, ranked, and visualized using SHapley Additive exPlanations (SHAP).
resultsTotally, 5,564 participants from CHARLS Wave 4 who met the eligibility criteria were enrolled in the analysis, of whom 1,862 exhibited depressive symptoms. The prevalence of depressive symptoms in this cohort was approximately one-third to one-half of that reported in populations with other chronic diseases. Among the 55 features, 17 potential predictors were selected. The eXtreme Gradient Boosting (XGBoost) model outperformed the others, achieving the highest area under the curve (AUC, 0.756) and lowest binary Brier score (0.180). This model also obtained an accuracy of 0.736, precision of 0.657, F1 score of 0.517, and specificity of 0.890. Based on SHAP values, nighttime sleep duration was the most influential of the 17 features in predicting depressive symptoms, followed by bodily pain, life satisfaction, self-reported health, and gender. The optimal XGBoost model, validated via five-fold cross-validation, was ultimately deployed as a web application for predicting depressive symptoms.
conclusionsUsing multidimensional data, the XGBoost, emerged as the top-performing model for predicting depressive symptoms among elderly individuals with chronic conditions, and this model was translated into an open-access, user-friendly interactive application. This work establishes a viable technical framework for precision public health strategies to enhance mental health in older adults with chronic comorbidities, enabling large-scale, low-cost population-level proactive health management. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.